Preparation and evaluation of the inclusion complex of silver sulfadiazine with cyclodextrin

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue SUPPL.1, 2013, Pages 461-468

  Hegazy, Aisha A ^a   Sharaf, Samar S ^a   El Feky, Gina S ^a   Shafei, Amira El ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Characterization; Complexation; Cyclodextrin; In vitro release; Silver sulfadiazine

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARBOXYMETHYL BETA CYCLODEXTRIN; CYCLODEXTRIN; SULFADIAZINE SILVER;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED RADIATION; INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; THERMAL ANALYSIS; WOUND HEALING;

EID: 84875424015     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Salas CL, Fernandez MM, Martinez AM. Topical chemotherapy for the treatment of burns. Rev. Enferm. 2005; 28: 67-70.
2. Wright JB, Hansen DL, Burrell RE. The Comparative efficacy of two antimicrobial barrier dressings: in vitro examination of two controlled release of silver dressings. Wounds 1998; 10: 179-88.
3. Fox CL. Silver sulphadiazine, addendum to local therapy. In: Modern treatment Hoeber Medical Division. New York: Harper and Row; 1967. p. 1259.
4. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000; 26: 131-8.
5. Stanford W, Rappole BW, Fox Jr CL. Clinical experience with silver sulphadiazine, a new topical agent for control of pseudomonas infections in burns. J. Trauma 1969; 9: 377-88.
6. Lansdown AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol. 2006; 33: 17-34.
7. Fox CL, Stanford JW. Anti-bacterial action of silver sulphadiazine and DNA binding. In: Matter P, Barcaly TL, Koni{dotless}óvá Z, editors. Research in burns. Bern: H. Huber Publishers; 1971. p. 133-138.
8. Taylor PL, Ussher AL, Burrell RE. Impact of heat on nanocrystalline silver dressings. Part I. Chemical and biological properties. Biomaterials 2005; 26: 7221-7229.
9. Higuchi T, Connors KA. Phase-solubility techniques. Adva Anal Chem Instr. 1965; 4: 212-217.
10. Chowadary KPR, Rao, KSP, Ayireddy A. A factorial study on the effects of cyclodextrins, poloxamer 407 and pvp on the solubility and dissolution rate of valsartan. Int J Pharm Pharmaceut Sci. 2012; 4: 285-287.
11. Challa R, Ahuja A., Ali J, Khar R. Cyclodextrins in Drug Delivery: An Updated Review. AAPS PharmSciTech. 2005; 06: E329-E357.
12. Ramachandray YL, Sudeep HV, Padmalathas SR, Ramadas K. Evaluation of wound healing activity of leaf extract of alstonia scholaris linn. In rats. Int J Pharm Pharmaceut Sci. 2012; 4 (supp1): 390-393.
13. Arima H, Yunomae K, Miyake K, Irie T, Hirayama F, Uekama K. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats. J Pharm Sci. 2001; 90: 690-701.
14. Ahmed MO. Comparison of impact of the different hydrophilic carriers on the properties of piperazine-containing drug. Eur J Pharm Sci. 2001; 51: 221-226.
15. Salústio PJ, Feio G, Figueirinhas JL, Pinto JF, Marques, HMC. The influence of the preparation methods on the inclusion of model drugs in a β-cyclodextrin cavity. Eur J Pharm Biopharm. 2009; 71: 377-386.
16. de Araujo DR, Tsuneda SS, Cereda CMS, Carvalho FDGF, Preté PSC, Fernandes S. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-β-cyclodextrin inclusion complex. Eur J Pharm Sci. 2008; 33: 60-71.
17. Fernandes CM, Vieira MT, Veigaa F. Physicochemical characterization and in vitro dissolution behavior of nicardipine cyclodextrins inclusion compounds. Eur J Pharm Sci. 2002; 15: 79-88.
18. Furo I. Pacsik K. Tompa R. Teeaar E. 13C NMR investigations of anhydrous and hydrated cyclomalto oligosaccharides: the role of water of hydration. Carb Res. 1987; 166: 27-33.
19. Winters CS, York P, Timmins P. Solid state examination of a gliclazide: beta-cyclodextrin complex. Eur J of Pharm Biopharm. 1997; 5: 209-214.
20. Eugene FF, Timothy AH. In: Lachmann L, Liberman HA and Kanig JL, Eds. The Theory and Practice of Industrial Pharmacy, 3rd Edn. Varghese Publishing House, Mumbai; 1987. P. 171.